Canaccord raised the firm’s price target on Boston Scientific (BSX) to $117 from $101 and keeps a Buy rating on the shares. The firm said they ...

CEO Michael Mahoney highlighted the company’s exceptional performance in 2024, with operational sales growth of 23% in Q4 and 18.5% for the full year. Organic sales grew 20% in Q4, exceeding guidance.

Learn more about whether Boston Scientific Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

Canaccord Genuity maintained its Buy rating on Boston Scientific (NYSE:BSX) shares and increased the price target to $117 from $101. The adjustment follows the company's robust fourth-quarter earnings ...

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Boston Scientific Corp (BSX) reports impressive Q4 2024 results with 22.4% revenue growth and a 26% increase in adjusted EPS, ...

If you are looking for stocks that have gained strong momentum recently but are still ... S&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as ...

The Boston College Eagles (10-11, 2-8 ACC) men’s basketball team finishes a two-game home stand with a game against the ...

Going into Wednesday’s game against the Rangers, the Bruins had a 5-0-1 record on their second night of back-to-back games.

J'Vonne Hadley led UofL's offensive charge with 22 points and brought down four rebounds. Terrence Edwards would add another ...

The Boston College Eagles (10-11, 2-8 ACC) men’s basketball team snapped its six-game losing streak with a 77-76 win over the ...